Clinical Trials Directory

Trials / Completed

CompletedNCT01075867

Multi-dimensional Prevention Program After Acute Coronary Syndrome (ELIPS) (SPUM-ACS- SP1)

Status
Completed
Phase
Study type
Observational
Enrollment
2,498 (actual)
Sponsor
University Hospital, Geneva · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To demonstrate the effectiveness of the ELIPS programme (Multi-dimEnsionaL preventIon Program after Acute coronary Syndrome), which aims at improving quality of care of patients admitted to hospital with Acute Coronary Syndrome (ACS) in the Swiss setting. The program targets an increase in prescription rates by physicians and long term medication adherence and adoption of healthy lifestyle attitudes by patients. The program is dedicated to caregivers to increase their application of guidelines into practice, to increase their confidence in therapeutic education of patients, and to patients to improve their understanding of ACS and its treatment and to increase their motivation for long term treatment,.

Conditions

Timeline

Start date
2010-04-01
Primary completion
2013-12-01
Completion
2018-12-01
First posted
2010-02-25
Last updated
2020-04-30

Locations

4 sites across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT01075867. Inclusion in this directory is not an endorsement.